Year: 2023
Type: article
Abstract: D.M.W. received research support from Daiichi Sankyo, Abcuro, and Secura, was a founder/equity holder of Ajax, Travera and Bantam, and is now an employee of Merck/MSD. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1002/hon.3182.
Source: Hematological Oncology
DOI: 10.1002/hon.3182
Author: David Weinstock
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4377140839